Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-20

FDA Approved: TIMOLOL MALEATE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for timolol maleate from Rising Pharma Holdings, Inc., authorizing changes to an existing generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Timolol maleate (Timolol maleate)

Snippet

SUPPL AP for TIMOLOL MALEATE (TIMOLOL MALEATE)